Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
25 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
19 Apr 23
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Regulation FD Disclosure
27 Mar 24
8-K
Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
25 Mar 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Topline Phase 2b data expected in June 2024
20 Nov 23
8-K
Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights
13 Nov 23
8-K
Aerovate Therapeutics Announces Second Quarter Financial Results and Business Highlights
14 Aug 23
8-K
Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors
11 Jul 23
8-K
Other Events
21 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
8 Jun 23
8-K
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
15 May 23
Registration and prospectus
S-8
Registration of securities for employees
8 Jan 24
424B5
Prospectus supplement for primary offering
5 Apr 23
S-8
Registration of securities for employees
29 Mar 23
S-3
Shelf registration
15 Aug 22
S-8
Registration of securities for employees
30 Mar 22
S-8
Registration of securities for employees
30 Jun 21
424B4
Prospectus supplement with pricing info
30 Jun 21
S-1MEF
Registration of additional securities for an S-1
29 Jun 21
8-A12B
Registration of securities on exchange
25 Jun 21
S-1/A
IPO registration (amended)
25 Jun 21
Other
EFFECT
Notice of effectiveness
24 Aug 22
CORRESP
Correspondence with SEC
19 Aug 22
UPLOAD
Letter from SEC
18 Aug 22
EFFECT
Notice of effectiveness
30 Jun 21
CERT
Certification of approval for exchange listing
29 Jun 21
CORRESP
Correspondence with SEC
25 Jun 21
CORRESP
Correspondence with SEC
25 Jun 21
CORRESP
Correspondence with SEC
24 Jun 21
UPLOAD
Letter from SEC
21 Jun 21
CORRESP
Correspondence with SEC
9 Jun 21
Ownership
4
Benjamin T Dake
19 Apr 24
4
Hunter Gillies
19 Apr 24
4
TIMOTHY P NOYES
18 Apr 24
144
Notice of proposed sale of securities
17 Apr 24
144
Notice of proposed sale of securities
17 Apr 24
144
Notice of proposed sale of securities
16 Apr 24
4
George A Eldridge
12 Apr 24
4
DAVID S. GRAYZEL
11 Apr 24
144
Notice of proposed sale of securities
9 Apr 24
4
TIMOTHY P NOYES
3 Apr 24